Arama sonuçlarınız

ISRO planning to launch second development SSLV flight in Feb: S Somanath ISRO is planning scientific missions to Mars and Venus and the Chandrayaan-3 mission is also planned for this year

Not loss of taste, smell. Know ‘classic’ symptom difference between common cold, flu, RSV, and Covid-19 The Union Health ministry in India had alerted in December 2022 that the coming 40 days would be crucial for the residents of India

Omicron's XBB.1.5 Sub-variant explained. Should India be worried of this strain? A new version of Omicron XBB.1.5 has raised concerns in many countries including India where its cases have been reported.According to experts, it has the capability to infect even those who have been vaccinated.

Centre launches ‘SMART’ program to boost scientific research through ayurveda colleges, hospitals The programme aims to boost scientific research in healthcare research areas through ayurveda colleges and hospitals, the Ministry of Ayush said

Child body weight has limited effects on mood and behavioral disorders: Study Childhood body mass index is unlikely to have a big impact on children's mood or behavioural disorders, according to a new study

NASA images show how Saturn's rings change as it travels around Sun On Saturn, a day only lasts for ten hours.

Study finds how glass frogs become transparent; see research here According to the findings of a recent study, glassfrogs make themselves transparent while they rest by taking red blood cells from circulation and concealing them in their livers.

ISRO missions 2023: Space start-up industry likely to boom next year ISRO will shift its emphasis to science investigations with dedicated missions.

How to detect petroleum underground? IIT Madras researchers explained The method was successful in providing critical information on the rock type distribution and hydrocarbon saturation zones at such depth zones of 2.3 km in 'Tipam formation' located in the Upper Assam basin.

Omicron BF.7, XBB and other Covid variants are circulating in India. Check key symptoms here Over 500 omicron variants are currently circulating worldwide and we are likely to see move Covid wave in the coming days

The most interesting success and failure of 2022 From the Webb telescope’s breathtaking images of space to a brilliant Star Wars show, this is what resonated over the past year—the good and the bad

Mandaviya reviews covid drug supply situation with pharma cos The minister reviewed covid essential medicines with Pharma Companies, asked them to keep a close watch on global supply chain scenario

Budget may bolster manufacturing of medical devices The proposed scheme is expected to complement the production-linked incentive scheme for medical devices.

Covid-19 vaccine booster dose increases durability of antibodies: Study The latest research on the booster dose stresses how the mRNA boosters from Pfizer and Moderna influence the persistence of our Covid-19 antibodies

Mental health firms thrive on misleading ads Telehealth companies are flooding TikTok, Instagram and other platforms with ads that don’t conform to standards governing the marketing of prescription drugs.

How artificial DNA can locate and eliminate cancer cells; see research here This procedure was successful in lab tests against cells generated from human cervical cancer, human breast cancer, and mouse malignant melanoma.

COVID in 2023: Why virus trends are more difficult to predict three years on So how will the pandemic be felt in 2023? This question is in some ways impossible to answer, given a number of unknowns

Here’s how doctors treat their own colds and flus With the country facing a barrage of illnesses, we asked ear, nose and throat specialists and family doctors which remedies they swear by

'Brain-eating amoeba' kills South Korean man within 11 day of returning from Thailand. Details here The Naegleria fowleri infection, also known as the ‘brain eating amoeba’ is usually found in warm freshwater bodies.

Drug prices reach new high — in the millions Several new drugs, most of them gene therapies, promise to cure or treat diseases in one course, but their price tags will test the health-insurance system.